Evidence map›Paper›PMID 40046891›Full record

ArticleOpen forum infectious diseases2025

Pulmonary Tuberculosis Infectiousness of Persons Identified Through Active and Passive Case-finding in a High-burden Setting.

Lilian N Njagi, Khai Hoan Tram, Jerry S Zifodya, Sharmila Paul, Jennifer M Ross, Wilfred Murithi, Zipporah Mwongera, Richard Kiplimo, Jane R Ong'ang'o, Kevin P Fennelly and 3 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lilian N NjagiCentre for Respiratory Diseases Research, Kenya Medical Research Institute, Nairobi, Kenya.ORCID https://orcid.org/0000-0002-5067-0788
Khai Hoan TramDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0003-1129-7674
Jerry S ZifodyaDepartment of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.ORCID https://orcid.org/0000-0003-2742-5976
Sharmila PaulDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Jennifer M RossDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0001-5677-939X
Wilfred MurithiCentre for Respiratory Diseases Research, Kenya Medical Research Institute, Nairobi, Kenya.ORCID https://orcid.org/0000-0002-4495-2957
Zipporah MwongeraCentre for Respiratory Diseases Research, Kenya Medical Research Institute, Nairobi, Kenya.
Richard KiplimoHealth Systems Strengthening Directorate, AMREF Health Africa, Nairobi, Kenya.
Jane R Ong'ang'oCentre for Respiratory Diseases Research, Kenya Medical Research Institute, Nairobi, Kenya.
Kevin P FennellyDivision of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
Thomas R HawnDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Videlis NdubaCentre for Respiratory Diseases Research, Kenya Medical Research Institute, Nairobi, Kenya.
David J HorneDepartment of Medicine, University of Washington, Seattle, Washington, USA.

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Aerobiology, immunology, and Mycobacterium tuberculosis transmissionR01AI150815 · NIAID · UNIVERSITY OF WASHINGTON · PI HAWN, THOMAS R, HORNE, DAVID J. · 2020 to 2024
$3.5M
Tuberculosis & HIV Co-Infection Training Program in KenyaD43TW011817 · FIC · UNIVERSITY OF WASHINGTON · PI Thomas R Hawn, VIDELIS NDUBA · 2021 to 2026
$1.6M
Mycobacterium tuberculosis aerobiology and novel tools to assess infectiousnessUH2AI152621 · NIAID · UNIVERSITY OF WASHINGTON · PI HORNE, DAVID J. · 2021 to 2022
$365k
FIC NIH HHS D43 TW011817NCATS NIH HHS UL1 TR002319NIAID NIH HHS R01 AI150815NIAID NIH HHS UH2 AI152621
6 · The paper itself

Abstract

Background: The role of active case-finding (ACF) in improving tuberculosis (TB) prevention and care depends on the infectiousness of persons with undiagnosed TB and the accuracy of screening strategies. To compare undiagnosed community dwellers to persons presenting for healthcare, we evaluated clinicodemographic and microbiologic characteristics, cough aerosol culture (CAC) status, and household contact (HHC) QuantiFERON-Plus (QFT) status by case-finding approach in adults with pulmonary TB. Methods: We enrolled 388 Kenyan adults with GeneXpert (excluding trace) and/or culture-confirmed, untreated TB through healthcare presentation (passive case-finding [PCF]; 87%) or ACF (community-based prevalence survey). Interventions included cough aerosol sampling and HHC QFT testing. We performed mixed-effect logistic regression to predict transmission, clustered on index participants. Results: World Health Organization-recommended screening symptoms (W4SS) were more common in the PCF cohort (99% vs 73%, Conclusions: Our findings suggest that ACF may detect a smaller proportion of CAC-positive persons with TB than PCF.

Indexed as

active case-findingaerosol samplingprevalent tuberculosissubclinical tuberculosistuberculosis infectiousness

Identifiers

PMID40046891
PMCPMC11880886

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.